...

Solving Quality Issues in Indian Pharma Imports

With more than 20% of the world’s exports of generic drugs, India has solidified its position as a major pharmaceutical hub (IBEF, 2023).

Indian pharmaceutical products are now vital to healthcare worldwide.

They are cost-effective, supported by a skilled workforce, and backed by a strong industrial system.

Despite these successes, concerns about quality still exist.

This has led to recalls, regulatory issues, and reputational damage for importers.

For reliable, high-quality pharmaceutical imports from India, we need strong quality control.

We also need active supplier management and deep industry knowledge.

This handbook offers a clear plan for importing safe, efficient, and legal medications.

It also looks at the reasons behind quality issues.

Understanding the Root Causes of Quality Variations

Diverse Manufacturing Ecosystem

The Indian pharmaceutical industry has global firms.

These companies hold certifications from the US FDA, EMA, and WHO-GMP.

It also has small to medium businesses that focus on the local market.

Big companies have strict quality processes.

Smaller organizations often lack the funds or technical know-how to meet global standards.

The uneven landscape suggests that product quality can differ a lot.

This variation can happen between different producers and even within the same company’s batches.

Regulatory Compliance Gaps

The CDSCO in India follows international rules.

However, monitoring and enforcement vary by state and region.

Inadequate training, inconsistent interpretation of requirements, or deliberate cost-cutting can cause compliance gaps.

Regulatory Compliance Gaps

High-profile events, like the recall of 1,394 medicine batches in 2023-24, highlight ongoing compliance gaps.

These batches failed quality tests (Economic Times, 2024).

This shows that problems still exist, even with improvements.

Supply Chain Complexities

The Indian pharmaceutical supply lines include contract manufacturers, packagers, distributors, and API providers.

Every handoff can hurt product quality. This can happen if storage, handling, or transit conditions are bad.

How to Select High-Quality Indian Suppliers

It takes a lot of research to find good Indian pharmaceutical sellers.

Companies that have a lot of experience exporting to controlled markets like the US and EU should be given more attention by importers.

This is because these companies usually keep higher quality standards.

Verifying that the supplier is a Pharmexcil member builds trust.

Independent audits of their facilities and methods ensure they meet international standards.

Batch testing before shipping in approved labs lowers risks even more.

By taking these steps, you can be sure of regular quality, cut down on rejected imports, and build trust with your Indian partners that will last.

Check Export Experience

You should choose providers who regularly send goods to markets with strict rules, like the US, EU, Canada, or Australia.

International organizations often review these manufacturers regularly.

They also maintain higher quality standards.

Checklist:

Evaluate Pharmexcil Membership

Pharmexcil is the Pharmaceuticals Export Promotion Council of India.

It manages the marketing of compliant exports.

By becoming a member, a business shows that it has been registered, checked out, and is committed to following India’s export rules.

Importance of Third-Party Quality Audits

Pre-Qualification Audits

Conduct in-person audits. Check documentation systems, standard operating procedures (SOPs), facilities, and quality control methods.

Batch-Wise Quality Testing

Prior to shipment release, every cargo should go through independent laboratory testing.

Regulatory-Compliant Testing Labs

For genuine results, use labs that have been prequalified by the WHO or ISO 17025.

Companies that use regular third-party audits cut their import rejections by up to 40%

Importance of Third-Party Quality Audits

Building Quality Agreements with Suppliers

Draft Detailed Quality Agreements

Define Consequences for Non-Compliance

Use Digital Contract Management

Supply Chain Integrity and Cold Chain Management

Ensure End-to-End Cold Chain

The success and safety of temperature-sensitive drugs hinge on a reliable cold chain from India to where they are needed.

Any mistake can lower vaccination, biological, and injectable quality.

Importers must ensure tight cold chain management during shipment and storage.

They should check that suppliers use approved cold storage systems.

Also, temperature-monitoring devices and qualified logistics partners are essential.

Track and Trace Technologies

The supply chain is more visible and reliable with track and trace technologies.

Pharmaceutical products are tracked in real-time. They use barcoding, serialization, and RFID tracking.

This helps reduce counterfeit and diverted medicines.

Importers can use strong tracking technology to find anomalies quickly.

This helps reduce theft and ensures full accountability from start to finish.

Reliable Logistics Partners

Pharmaceutical transportation experts must be chosen to maintain product quality.

The WHO says that bad cold chain management leads to 25% of vaccine loss in low-income countries.

So, partners with proven temperature control, real-time tracking, and regulatory certifications are essential.

Logistics partners reduce transit risks, ensure timely deliveries, and protect important pharmaceutical supplies.

Continuous Supplier Development Programs

Regular Supplier Training

Performance Monitoring

Continuous Supplier Development Programs

Feedback Loops

Staying Ahead of Regulatory Updates

Monitor CDSCO Updates

Following CDSCO updates is crucial for Indian pharmaceutical compliance.

CDSCO updates production, product recall, and export certification warnings and adjustments often.

Importers can watch their website and circulars.

This helps them expect regulatory changes.

It also ensures suppliers follow the rules and cut down on shipment delays and compliance issues.

Subscribe to Importing Country Regulations

Importers must stay updated on pharmaceutical laws.

They should subscribe to regulatory bulletins, newsletters, and government updates.

All markets—US FDA, EMA, TGA, and others—update drug import, labelling, testing, and documentation criteria.

Regular monitoring of these adjustments ensures that Indian goods adhere to legal and quality requirements.

This helps reduce border holds and rejections.

Engage Compliance Consultants

Consult regulatory compliance professionals to streamline pharmaceutical import compliance.

These experts help suppliers navigate complex regulations and audit papers and advise on changes.

Their help can reduce costly mistakes. It can improve supplier responsibility.

It also boosts quality assurance plans for pharmaceutical importers.

Conclusion

India is still a leader in developing new medicines that are affordable and helping to fund healthcare around the world.

Navigating quality risks in the diverse pharmaceutical manufacturing ecosystem requires careful planning.

It needs strong quality control systems.

It also requires smart partnerships with suppliers and a commitment to continuous improvement.

Importers can leverage India’s strengths while ensuring patient safety. Choose dependable suppliers.

Conduct thorough audits. Keep the supply chain honest. Stay informed about global regulations.

A proactive, organized, and tech-savvy approach lowers risks.

It also gives pharmaceutical importers a long-term advantage in the ever-changing global market.

Request A Call Back